Early research (Phase 1)Study completedNCT07342868
What this trial is testing
Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Pevifoscorvir Sodium (ALG-000184) in Subjects With Moderate Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function
Who this might be right for
Chronic Hepatitis B Infections
Aligos Therapeutics 20